A newspaper reported that a new technique called radiofrequency ablation has given hope to patients with small malignant lung tumours that could not be treated with sugery, radiotherapy or chemotherapy.
Researchers said it has produced good response rates and is safe to warrant further study after they recruited 106 patients for the study and found that the new technique successfully treated 88% of tumours and about 50% of patients who had primary lung cancer were alive after two years. The study was funded by Angiodynamics which made the radiofrequency ablation device.
Source: "Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)." Lancet Oncology 2008; Jun 18 [Epub ahead of print]
No comments:
Post a Comment